Orforglipron (NEW)with Chromium Picolinate 1mg

Name: Orforglipron (NEW)with Chromium Picolinate 1mg 0.8 mg (30 capsules)
Brand: PureVital
SKU: PV-ORFORGLIPRON-NEW-WITH-CHROMI-0.8MG30CAPSULES
Price: 143.99 USD
Availability: InStock

Oral non-peptide GLP-1 option with chromium support

PV-ORFORGLIPRON-NEW-WITH-CHROMI-0.8MG30CAPSULES

Professional price

$143.99

View monograph

Orforglipron is an oral small-molecule GLP-1 receptor agonist of high interest for clinics seeking capsule-based adherence. PureVital presentations include Chromium Picolinate 1 mg as a supportive micronutrient co-factor in the capsule line. Presentation: 0.8 mg (30 capsules) (Capsules); total API 2.4 mg. For licensed clinics and practitioners.

Oral non-peptide GLP-1 option with chromium support
Strength: 0.8 mg (30 capsules)
Total API: 2.4 mg
Capsules presentation for licensed clinic programs

Licensed clinic formulary

Label-first SKU detail

Wholesale & bulk desk

PureVital Clinical Formulary — Strength & Volume updates April 2026

Mechanism themes

Receptor and pathway context written for clinic teams.

Clinic-use references

Titration and presentation notes — not patient prescriptions.

Safety & regulatory

Precautions, interactions, and status framing in one monograph.

Clinical monograph

Professional product details

Oral non-peptide GLP-1 option with chromium support. Structured for licensed clinics — mechanism, clinic-use themes, safety, and package clarity in one place.

Compound family

orforglipron

Overview

Label-first clinic supply presentation

Contents of the package

What arrives for this PureVital SKU

1 × 0.8 mg (30 capsules) capsules presentation
Active listing: Orforglipron (NEW)with Chromium Picolinate 1mg
Total API (label): 2.4 mg
SKU PV-ORFORGLIPRON-NEW-WITH-CHROMI-0.8MG30CAPSULES
Oral capsule bottle — store per label away from moisture
PureVital professional clinical formulary supply

About Orforglipron capsules

Oral GLP-1 pathways can reduce injection burden. Strength ladders (0.8 mg through 17.2 mg capsule strengths in this formulary) let clinics stage escalation similar in spirit to injectable titration — always confirm the labeled capsule strength before prescribing.

Mechanism & co-factor

Non-peptide GLP-1 receptor agonism via oral route
Chromium picolinate included as a metabolic support micronutrient in these SKUs
Daily oral schedules may improve adherence for needle-averse patients

Clinic use notes

Start low

Assess GI

Escalate

Maintain

Match capsule strength to the patient’s titration step
Counsel on GI expectations during dose changes
Review drug–food timing guidance used in your oral GLP SOP

Safety

Incretin-class GI adverse effects possible
Screen for class contraindications before initiation
Document off-label or evolving-evidence discussions as required

Regulatory context

Approval and labeling status for orforglipron continue to evolve by jurisdiction. Use only within compliant professional frameworks.

Educational formulary information for licensed clinics and practitioners only. PureVital presents professional supplement / wellness formulary items — not regular medicines. Final presentation choice, titration, and monitoring remain clinical decisions. Not intended to diagnose, treat, cure, or prevent any disease.

Continue browsing